Acer Medical Inc. (TPEX:6857)

Taiwan · Delayed Price · Currency is TWD

90.00

0.00 (-1.64%)

Sep 4, 2026, 12:58 PM CST

Acer Medical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	70.47	60.05	50.16	27.45	13.06	9.63
Revenue Growth	17.34%	19.73%	82.73%	110.17%	35.66%	849.41%
Gross Profit	46.24	37.5	31.67	12.88	6.14	6.44
Operating Income	-26.6	-32.73	-30.2	-41.16	-55.18	-20.53
Net Income	-23.69	-29.69	-27.36	-38.18	-54.71	-20.45
Earnings Per Share	-1.56	-1.95	-1.80	-2.51	-4.43	-2.64
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Smart Medical	53.69	42.09	24.42	11.77	13.06
Health Care Products	16.78	17.97	25.74	15.68	-
Total	70.47	60.05	50.16	27.45	13.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	153.77	178.65	202.78	220.03	276.56	129.68
Total Debt	-	2.5	-	-	-	-
Net Cash (Debt)	153.77	176.15	202.78	220.03	276.56	129.68
Net Cash Growth	-12.71%	-13.13%	-7.84%	-20.44%	113.26%	199.06%
Net Cash Per Share	10.10	11.57	13.32	14.45	22.42	16.73

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-23.96	-24.65	-20.7	-53.13	-45.77	-18.82
Capital Expenditures	-1.39	-1.08	-	-	-3.2	-0.51
Free Cash Flow	-25.35	-25.73	-20.7	-53.13	-48.97	-19.32
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	65.62%	62.45%	63.15%	46.94%	46.98%	66.85%
Operating Margin	-37.75%	-54.51%	-60.20%	-149.96%	-422.49%	-213.28%
Pretax Margin	-33.62%	-49.43%	-54.56%	-139.10%	-418.88%	-212.38%
Profit Margin	-33.62%	-49.43%	-54.56%	-139.10%	-418.88%	-212.38%
FCF Margin	-35.97%	-42.84%	-41.27%	-193.57%	-374.94%	-200.71%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	19.45	25.10	43.11	103.18	85.11	117.79